Wei‐Ming Su
Impact in
- Neurology top 10%
- Amyotrophic Lateral Sclerosis Research
- Parkinson's Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
-
- Genetic Associations and Epidemiology
Papers in
- Neurology 18
- Amyotrophic Lateral Sclerosis Research 10
- Parkinson's Disease Mechanisms and Treatments 7
-
- Dementia and Cognitive Impairment Research 4
- Schizophrenia research and treatment 1
- Co-authors
- Yong‐Ping Chen (25 shared papers)Qing‐Qing Duan (21 shared papers)Zheng Jiang (10 shared papers)Xiaojing Gu (19 shared papers)Bei Cao (19 shared papers)Yi Wang (8 shared papers)Huifang Shang (5 shared papers)Yangfan Cheng (2 shared papers)
- Journals
- BMC Medicine (3 papers)Journal of Neurology Neurosurgery & Psychiatry (2 papers)Molecular Neurobiology (2 papers)npj Parkinson s Disease (2 papers)Archives of Gerontology and Geriatrics (1 paper)
- Partner nations
- China
In The Last Decade
Wei‐Ming Su
22 papers receiving 373 citations
Wei‐Ming Su's Hit Papers
Peers
Comparison fields: 5 of 48
- Neurology 158
- Genetics 78
- Physiology 52
- Neurology 14
- Psychiatry and Mental health 31
Countries citing papers authored by Wei‐Ming Su
This map shows the geographic impact of Wei‐Ming Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Ming Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Ming Su more than expected).
Fields of papers citing papers by Wei‐Ming Su
This network shows the impact of papers produced by Wei‐Ming Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Ming Su. The network helps show where Wei‐Ming Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei‐Ming Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Systematic druggable genome-wide Mendelian randomisation identifies therapeutic targets for Alzheimer’s disease Hit paper breakdown → | 2023 | 102 |
| 2 | 2021 | 70 | |
| 3 | 2023 | 31 | |
| 4 | 2024 | 29 | |
| 5 | 2022 | 27 | |
| 6 | 2024 | 24 | |
| 7 | 2023 | 22 | |
| 8 | 2022 | 13 | |
| 9 | 2022 | 10 | |
| 10 | 2021 | 8 | |
| 11 | 2023 | 7 | |
| 12 | 2024 | 7 | |
| 13 | 2021 | 5 | |
| 14 | 2023 | 4 | |
| 15 | 2024 | 4 | |
| 16 | 2024 | 3 | |
| 17 | 2025 | 3 | |
| 18 | 2022 | 2 | |
| 19 | 2024 | 2 | |
| 20 | 2025 | 2 |
About Wei‐Ming Su
Wei‐Ming Su is a scholar working on Neurology, Psychiatry and Mental health, Genetics, Physiology and Neurology, having authored 27 papers that have together received 377 indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (10 papers), Parkinson's Disease Mechanisms and Treatments (7 papers), Genetic Associations and Epidemiology (6 papers), Alzheimer's disease research and treatments (4 papers), Dementia and Cognitive Impairment Research (4 papers), Pluripotent Stem Cells Research (1 paper), Schizophrenia research and treatment (1 paper) and Mitochondrial Function and Pathology (1 paper). The work is most often cited by research in Neurology (158 citations), Genetics (78 citations), Physiology (52 citations), Neurology (14 citations) and Psychiatry and Mental health (31 citations). Wei‐Ming Su has collaborated with scholars based in China. Frequent co-authors include Yong‐Ping Chen, Qing‐Qing Duan, Zheng Jiang, Xiaojing Gu, Bei Cao, Yi Wang, Huifang Shang, Yangfan Cheng, Tianmi Yang and Xia Gao. Their work appears in journals such as BMC Medicine, Journal of Neurology Neurosurgery & Psychiatry, Molecular Neurobiology, npj Parkinson s Disease and Archives of Gerontology and Geriatrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.